Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
The model’s consistent overall accuracy demonstrates the reusability of existing COVID algorithms with recalibrations rather than fallbacks to square one, AI developers suggest.
Medicare is associated with reductions in racial and ethnic disparities in insurance coverage, access to care and self-reported health across the U.S., according to a new study published in JAMA.
Researchers in Denmark and the U.S. have used deep neural networks to develop complementing models for predicting complications likely to arise in patients who’ve had surgeries of all kinds.
When assisted by an AI tool designed to organize and display digitized patient referral records, gastroenterologists cut their time to answer relevant clinical questions by 2.3 minutes.
Beginning around 2031, autonomous virtual assistants will deliver precision preventive medicine while networked provider orgs offer closely connected care via single, shared digital infrastructures.
Early on in the development of digital image recognition, the technology showed a penchant for taking logical but potentially problematic shortcuts: It would look to image artifacts and incidental “asides” such as background features to distinguish between two visually similar subjects.
Psychology researchers have used machine learning to wring useful two-year dementia trajectory predictions from more than 500 potentially contributing risk factors.
Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more.
Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.
When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country.